K2 Principal Fund’s Atea Pharmaceuticals AVIR Stock Holding History

K2 Principal Fund’s Portfolio AVIR Stock Details AVIR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$3.44M	Sell
2022 Q2	$11.4M	Buy